Feb 26, 2026 06:45PM
Feb 23, 2026 04:05PM
Feb 17, 2026 05:05PM
Jan 30, 2026 04:30PM
Jan 29, 2026 07:30AM
Jan 29, 2026 07:30AM
Jan 12, 2026 06:15AM Summit Therapeutics partners with GSK for cancer drug combination trial
Jan 12, 2026 06:15AM
Jan 12, 2026 06:01AM
Jan 12, 2026 06:00AM
Jan 9, 2026 08:16PM
Jan 6, 2026 07:30AM
Dec 5, 2025 04:30PM
Nov 7, 2025 09:02AM Ivonescimab shows survival benefit in lung cancer study
Nov 7, 2025 09:00AM
Nov 4, 2025 07:00AM
Oct 31, 2025 07:00AM
Oct 31, 2025 07:00AM
Oct 22, 2025 08:00AM
Oct 22, 2025 08:00AM
Oct 20, 2025 06:45AM Summit Therapeutics plans to submit BLA for cancer drug in Q4 2025
Oct 20, 2025 06:45AM
Oct 19, 2025 10:30AM
Oct 17, 2025 07:00AM
Oct 17, 2025 07:00AM
Oct 15, 2025 07:00AM
Sep 24, 2025 04:30PM
Sep 24, 2025 07:00AM Summit presents lung cancer trial data at ESMO 2025
Sep 24, 2025 07:00AM
Sep 7, 2025 03:30AM
Sep 3, 2025 07:00AM
Aug 14, 2025 07:00AM
Aug 11, 2025 05:03PM
Jun 30, 2025 08:07AM
Jun 30, 2025 08:00AM Revolution Medicines and Summit Therapeutics Enter Into Clinical Collaboration to Evaluate Combinations of Three RAS(ON) Inhibitors With Ivonescimab in RAS Mutant Tumors
Jun 6, 2025 04:44PM
Jun 5, 2025 08:00AM
May 30, 2025 07:54AM
May 30, 2025 06:00AM
May 16, 2025 04:30PM
May 1, 2025 04:09PM
Apr 25, 2025 02:52PM Summit Therapeutics (SMMT): Interim OS Analysis Requested from Chinese Health Authorities Shows Clinically Meaningful, Positive Trend Favoring Ivonescimab Compared to Pembrolizumab in PD-L1 Positive A
Apr 25, 2025 02:50PM
Apr 24, 2025 04:15PM
Apr 23, 2025 06:15AM
Apr 4, 2025 04:15PM
Mar 21, 2025 04:16PM
Mar 21, 2025 04:15PM
Mar 17, 2025 04:24PM Summit Therapeutics (SMMT) appoints Robert LaCaze as CCO
Mar 17, 2025 04:24PM

12,645 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All